Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System

Abstract

The angiopoietin-Tie-2 system plays a crucial role in the maintenance of endothelial integrity. Hyperglycemia and advanced glycation end-products (AGEs) are involved in endothelial cell dysfunction responsible of the pathogenesis of microvascular complications of diabetes. Here, we investigated whether glycated serum (GS) or hyperglycemia (HG) affect the angiopoietin-Tie-2 system in the microvascular endothelial cells HMEC-1. We found that culture for 5 days in the presence of AGEs and HG (alone or in combination) decreased cell proliferation, increased reactive oxygen species (ROS) production, and reduced ratio between the oxidized and the reduced form of glutathione. Since angiopoietin-1 (Ang-1) signaling regulates angiopoietin-2 (Ang-2) expression through inactivation of the forkhead transcription factor FoxO1, we investigated intracellular signaling of Ang-1 and expression of Ang-2. HG and AGEs reduced phosphorylation of Akt and abrogated phosphorylation of FoxO1 induced by Ang-1 without affecting neither Tie-2 expression nor its activation. Furthermore, AGEs and/or HG induced nuclear translocation of FoxO1 and increased Ang-2 production. In conclusion, we demonstrated that both hyperglycemia and AGEs affect the angiopoietin-Tie-2 system by impairing Ang-1/Tie-2 signaling and by increasing Ang-2 expression. These results suggest that therapeutic strategies useful in preventing or delaying the onset of diabetic vascular complications should be aimed to preserve Ang-1 signaling.

Engeletin protects against cerebral ischemia/reperfusion injury by modulating the VEGF/vasohibin and Ang-1/Tie-2 pathways

“…Ang-1 is an oligomeric glycoprotein that binds to and signals through Tie-2 ( 32 ), thereby enhancing vascular stability and modulating associated permeability. Ang-1 binding to Tie-2 induces intracellular signaling that regulates endothelial cell survival, migration, and permeability ( 33 ). In contrast, Ang-2 functions as an antagonist that prevents Ang-1-induced Tie-2 phosphorylation, driving extensive angiogenesis and vascular destabilization ( 34 ).…”

Diabesity in Elderly Cardiovascular Disease Patients: Mechanisms and Regulators

“…The senescence induced by ageing and diabetes can disrupt the endothelial function because of reactive oxygen species (ROS), inflammatory mediators or inducible nitric oxide (iNO) [ 4 ]. The dysfunctional metabolism of endothelial cells produces advanced glycation end products (AGEs) that through their receptors (RAGEs) activate mitogen-activated protein kinase (MAPK) and NFκB cascades and increase the production of ROS [ 84 ], inflammatory (vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1)) [ 85 ], profibrotic (matrix metalloproteinase (MMP)-2 protein) and prothrombotic factors (von Willebrand, plasminogen activator inhibitor-1 (PAI-1) and tissue factor (TF)) [ 86 ]. They are contributors to arterial stiffness, vascular calcification, and plaque accumulation in atherosclerosis-prone vessels and, consequently, diabetes mellitus-related vascular complications [ 87 ].…”

Emerging therapeutic potential of adeno-associated virus-mediated gene therapy in liver fibrosis

“… 88 Abnormal accumulation of AGEs occurs in the presence of persistent hyperglycemia. 89 The study by Dehnad et al. reported that continued exposure to AGEs in the liver led to an imbalance between AGEs clearance receptor (AGER1) and receptor for AGEs (RAGE), consequently resulting in excessive redox, inflammatory, and fibrogenic activity in NASH, which is mediated by NADPH oxidase 4 in hepatocytes.…”